Result Summary for 208127/100 and 208127/101 (Ext-HAB-075)
| Protocol ID: | 208127/100 and 208127/101 (Ext-HAB-075) |
| Clinical Study ID: | 208127/100 and 208127/101 (Ext-HAB-075) |
| Official Title: | A double-blind study to compare the immunogenicity, safety and reactogenicity of GSK Bios’ high-dose combined hepatitis A/B vaccine containing 1440 EL.U of hepatitis A antigen/40 mcg of hepatitis B surface antigen to that of Twinrix™, both admin following a 0-6 mth schedule in healthy adolescents |
| Phase: | Phase 3 |
| Study Indications or Diseases: |
|
| Generic Name: | Hepatitis A (Inactivated), Hepatitis B (Recombinant) Vaccine |
| Trade/Product Name: | Twinrix;Twinrix |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
